The U.S. FDA has approved our therapy for certain people with pre-treated HR+/HER2- metastatic breast cancer.
Read more.

Advancing Health Equity

Gilead is committed to driving positive societal impact. Our culture of giving back has helped define Gilead as a company. Gilead’s philanthropic programs reflect our commitment to support the communities in which we live and work, the people impacted by life-threatening diseases and our employees’ desire to drive positive impact around the world.

$200 Million Endowment to Gilead Foundation Will Address Root Causes of Health Disparities

In 2021, we announced a new $200 million endowment to the Gilead Foundation. The expansion will help address the underlying social, economic and environmental factors that contribute to the health and wellbeing of individuals in the U.S. and around the world.

FPO

“We [Gilead] need to address the underlying social, economic and environmental factors that contribute to the health and wellbeing of individuals in the United States and around the world to create a broader path to healthcare prosperity.”

Keeley Wettan, Senior Vice President, Legal, Gilead Sciences, Inc., and Chair of the Gilead Foundation

Power Within Reach | Working to End the HIV Epidemic Through Our COMPASS Initiative®

Gilead launched the COMPASS Initiative in the Southern United States with the goal of reaching the communities most impacted by the HIV epidemic. In 2021, Wake Forest University School of Divinity was added as a coordinating center, expanding the program into faith-based communities, including the Black church. Through COMPASS, Gilead is providing $5 million in grant funding over three years to Wake Forest. The University became the fourth coordinating center for COMPASS, joining Emory University Rollins School of Public Health, Southern AIDS Coalition and the University of Houston Graduate College of Social Work. Through Gilead’s work with the coordinating centers and direct engagement with partners in the region, the company has provided more than $74 million in funding to the Southern United States in support of 326 organizations as of December 2021. Gilead has committed to providing more than $100 million through COMPASS over 10 years.

View Transcript

Dean Walton: We've placed so much attention in the modern West on freedom, on individuality, and autonomy. And in the process, we've actually diminished some of the great ethical teachings of our faith traditions as it relates to what we owe the other. That's what social justice is about. It's about living our lives in such a way in our communities and structuring our society and world where we take care of the other.

 

Dean Jones: At Wake Forest, we talk about our motto, Pro Humanitate, for humanity. So that our enterprise for educating is not just for the sake of learning. We are doing the work that we do here at Wake Forest for humanity.

 

Dean Walton: HIV and AIDS is a human problem--disproportionately impacting the African-American community. At Wake Forest University School of Divinity, we believe that black lives matter, full stop.

 

Dean Jones: We know that nearly half of new diagnoses for HIV occurs in the Southern United States.

 

Dean Walton: I believe that communities of faith are central to helping change those narratives.

 

Dean Jones: Part of our excitement about connecting with the Gilead COMPASS Initiative is this recognition that in the South, you cannot effectively address HIV and AIDS without thinking about faith communities.

 

Dean Walton: COMPASS Initiative understands that if we really want to curb the negative impact of HIV and AIDS in the southern region, that we have to take a multi-prong approach. We have to engage with LGBTQ activist organizations. We have to engage with communities of faith. We have to engage with other health organizations. People who are doing the heavy work of human services.

 

Dean Jones: We'll know we're making progress when we've eradicated the disease. We'll know we're making progress when transformative storytelling takes hold and faith communities are telling a new story, and the disease is not stigmatized in the way that it is now. We will know that we are making progress when LGBTQ persons can live free and wholly in their faith communities without judgement and not have the need to be silent about who they are and who they love.

 

Dean Walton: It doesn't matter your sexuality, it doesn't matter your class, whether one is a Christian, a Muslim, whether one's Buddhist, HIV and AIDS is impacting our community.

 

Dean Walton: When we're able to walk into any African-American church in the south and see that they are addressing HIV and AIDS, doing testing, helping people with their medicine, when they're doing that in the same ways as they currently dodiabetes screenings or blood pressure screenings right now in their health ministries, I know that we've made a difference.

Zeroing In™

In 2021, we announced Zeroing In, a global funding opportunity announcement to support efforts around ending the HIV epidemic around the world. Through Zeroing In, Gilead is making a significant contribution to organizations offering local HIV innovation programs, digital health solutions and community outreach and education in their respective city, state, country or region.

FPO

HepConnect: Closing the Gap in Hepatitis C Care

In 2021, more than 200,000* people were reached through HepConnect, our five-year, multimillion-dollar initiative aimed at addressing the increase in hepatitis C infections fueled by the opioid crisis. Gilead works through local organizations in Indiana, Kentucky, North Carolina, Tennessee and West Virginia to expand screenings and linkage to care, support harm reduction and community education, and build knowledge, resources and capacity in communities where needs are greatest. The number of harm reduction kits distributed totaled 12 million, up from 8 million in 2020.

*Number may include duplicates

FORWARD AND
ONWARD TOGETHER

View Full Report (PDF)